http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-102014014857-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c80a320443e9a6b4f4d1a6566a2305ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee9e19fe8da676dc532a84d0ced6fa44 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 |
filingDate | 2014-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7f187f98516c40b34211e4782262411 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02814325061190c0979620a715b59b44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15d535c1468043b127e664e18eb76833 |
publicationDate | 2015-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | BR-102014014857-A2 |
titleOfInvention | Composition with a proton pump inhibitor and an h2 antagonist |
abstract | Abstract "composition with a proton pump inhibitor and an h2 antagonist" the present invention relates to an oral pharmaceutical composition comprising the combination of a proton pump inhibitor (ibp) and an h2 antagonist (ah2) and their salts pharmaceutically acceptable, additionally pharmaceutically acceptable carriers or excipients; as well as a process for the manufacture of the composition and the use of the rabeprazole-famotidine or dexrabeprazole-famotidine combination with synergistic therapeutic activity indicated for the treatment of gastroesophageal reflux diseases (drge), nocturnal acid escape (nab), peptic ulcer and/ or eradication of h. Pylori. |
priorityDate | 2013-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 356.